Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers-Reference-Cited by-同舟云学术

Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers

Published:1982-05 Issue:5 Volume:25 Page:487-504
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Samsioe Göran

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference35 articles.

1. High density lipoprotein as a protective factor against coronary heart disease;Gordon;Amer J of Medicine,1977

2. Risk factors for myocardial infarction in young women;Mann;Brit J of Preventive and Social Medicine,1976

3. Plasma high density-lipoprotein concentration and development of ischaemic heart disease;Miller;Lancet,1975

4. Mortality among oral-contraceptive users;Royal College of General Practiotioners Oral Contraceptions Study;Lancet,1977

5. Oral contraceptives and myocardial infarction;Shapiro;New Engl J of Medicine,1975

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biology: risk factor modification by OCs and HRT lipids and lipoproteins;Maturitas;2004-04

2. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial;American Journal of Obstetrics and Gynecology;1999-11

3. Effects of Oral Contraceptives on Coagulation Factors in African Women;Thrombosis Research;1998-04

4. Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis**Supported by a grant from Ortho-McNeil Pharmaceutical Corporation, Raritan, New Jersey.;Fertility and Sterility;1996-06

5. Twelve years of clinical experience with an oral contraceptive containing 30μg ethinyloestradiol and 150μg desogestrel;Contraception;1995-01